Table 2

Adverse events possibly, probably, or definitely associated with protocol therapy

Toxicity typeAny gradeGrade 1Grade 2Grade 3Grade 4
Anemia 3 (9.7%) 0 (0%) 2 (6.5%) 1 (3.2%) 0 (0%) 
Arthralgia 3 (9.7%) 3 (9.7%) 0 (0%) 0 (0%) 0 (0%) 
Azotemia 3 (9.7%) 1 (3.2%) 2 (6.5%) 0 (0%) 0 (0%) 
Cardiomyopathy 1 (3.2%) 0 (0%) 0 (0%) 1 (3.2%) 0 (0%) 
Chest pain (non-cardiac) 1 (3.2%) 0 (0%) 1 (3.2%) 0 (0%) 0 (0%) 
Dyspepsia 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 0 (0%) 
Fatigue 2 (6.5%) 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 
Hyperglycemia 31 (100%) 7 (22.6%) 17 (54.8%) 7 (22.6%) 0 (0%) 
Hyperamylasemia 8 (25.8%) 7 (22.6%) 1 (3.2%) 0 (0%) 0 (0%) 
Hyperbilirubinemia 9 (29.0%) 7 (22.6%) 2 (6.5%) 0 (0%) 0 (0%) 
Hyperkalemia 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 0 (0%) 
Hyperlipasemia 17 (54.8%) 4 (12.9%) 8 (25.8%) 5 (16.1%) 0 (0%) 
Hypokalemia 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 0 (0%) 
Insomnia 2 (6.5%) 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 
Infusion reaction (rituximab) 7 (22.6%) 1 (3.2%) 6 (19.4%) 0 (0%) 0 (0%) 
Mucositis 2 (3.2%) 2 (3.2%) 0 (0%) 0 (0%) 0 (0%) 
Neutropenia 11 (34.8%) 7 (22.6%) 1 (3.2%) 2 (6.5%) 1 (3.2%) 
Peripheral neuropathy 6 (19.4%) 5 (16.1%) 1 (3.2%) 0 (0%) 0 (0%) 
Rash 9 (29.0%) 6 (19.4%) 3 (9.7%) 0 (0%) 0 (0%) 
Thrombocytopenia 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 0 (0%) 
Toxicity typeAny gradeGrade 1Grade 2Grade 3Grade 4
Anemia 3 (9.7%) 0 (0%) 2 (6.5%) 1 (3.2%) 0 (0%) 
Arthralgia 3 (9.7%) 3 (9.7%) 0 (0%) 0 (0%) 0 (0%) 
Azotemia 3 (9.7%) 1 (3.2%) 2 (6.5%) 0 (0%) 0 (0%) 
Cardiomyopathy 1 (3.2%) 0 (0%) 0 (0%) 1 (3.2%) 0 (0%) 
Chest pain (non-cardiac) 1 (3.2%) 0 (0%) 1 (3.2%) 0 (0%) 0 (0%) 
Dyspepsia 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 0 (0%) 
Fatigue 2 (6.5%) 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 
Hyperglycemia 31 (100%) 7 (22.6%) 17 (54.8%) 7 (22.6%) 0 (0%) 
Hyperamylasemia 8 (25.8%) 7 (22.6%) 1 (3.2%) 0 (0%) 0 (0%) 
Hyperbilirubinemia 9 (29.0%) 7 (22.6%) 2 (6.5%) 0 (0%) 0 (0%) 
Hyperkalemia 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 0 (0%) 
Hyperlipasemia 17 (54.8%) 4 (12.9%) 8 (25.8%) 5 (16.1%) 0 (0%) 
Hypokalemia 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 0 (0%) 
Insomnia 2 (6.5%) 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 
Infusion reaction (rituximab) 7 (22.6%) 1 (3.2%) 6 (19.4%) 0 (0%) 0 (0%) 
Mucositis 2 (3.2%) 2 (3.2%) 0 (0%) 0 (0%) 0 (0%) 
Neutropenia 11 (34.8%) 7 (22.6%) 1 (3.2%) 2 (6.5%) 1 (3.2%) 
Peripheral neuropathy 6 (19.4%) 5 (16.1%) 1 (3.2%) 0 (0%) 0 (0%) 
Rash 9 (29.0%) 6 (19.4%) 3 (9.7%) 0 (0%) 0 (0%) 
Thrombocytopenia 1 (3.2%) 1 (3.2%) 0 (0%) 0 (0%) 0 (0%) 

Numbers given as number (percentage) of events.

or Create an Account

Close Modal
Close Modal